Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity

AIDS Research and Human Retroviruses

Volumn 12, Issue 10, 1996, Pages 885-892

  Dudhane, Anita ^a   Conti, Bruno ^a   Orlikowsky, Thorsten ^a   Wang, Zhi Qin ^a   Mangla, Neeraj ^a   Gupta, Asha ^a   Wormser, Gary P ^a   Hoffmann, Michael K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ENVELOPE;

EID: 0030003417     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.885     Document Type: Article

References (39)

1. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, and Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333.
2. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183.
3. Riethmuller G, Rieber RB, Kiefersauer S, Prinz J, van der Lubbe B, Meiser B, Breedvelt F, Eisenburg J, Kruger K, Deusch K, Sanders M, and Reiter C: From to therapeutic monoclonal antibodies: First experiences with a chimeric CD4 antibody in the treatment of autoimmune disease. Immunol Rev 1992;129:81.
4. + T cells from HIV infected asymptomatic individuals. J Exp Med 1992;175:331.
5. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, and Miedema F: Programmed death of T cells in HIV-1 infection. Science 1992;257:217.
6. Daniel V, Susal C, Weimer R, Zimmermann R, Huth-kuhne A, and Opelz G: Association of T cell and macrophage dysfunction with surface gp120-immunoglobulin-complement complexes in HIV-infected patients. Clin Exp Immunol 1993;93:152.
7. Gougeon M, Garcia S, Heeney J, Tscopp R, Lecoeur H, Guetard D, Rame V, Dauguet C, and Montagnier L: Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 1993;9:553.
8. Ameisen JC and Capron A: Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis. Immunol Today 1991;12:102.
9. Schwartz RH: Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:10065.
10. Linsley PS and Ledbetter J: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191.
11. June CH, Bluestone JA, Nadler LM, and Thomson CB: The B7 and CD28 families. Immunol Today 1994;15:321.
12. Carteron N, Wofsy D, and Seaman WE: Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells. J Immunol 1988;140:713.
13. Qin S, Cobbald H, Tighe H, Benjamin R, and Waldmann H: CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 1987;17:1159.
14. Choy EH, Adjaye J, Forrest L, Kingsley GH, and Panayi GS: Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fc gamma receptor mediates apoptosis of human CD4 lymphocytes. Eur J Immunol 1993;23:2676.
15. Wang Z, Dudhane A, Orlikowsky T, Clarke K, Li X, Darzynkiewicz Z, and Hoffmann MK: CD4 engagement induces Fas Ag dependent apoptosis of T cells in vivo. Eur J Immunol 1994;24:1549.
16. Wang ZQ, Orlikowsky T, Dudhane A, Mittler R, Blum M, Lacy E, Riethmüller G, and Hoffmann MK: Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS-patients. Eur J Immunol 1994;24:1553.
17. Oyaizu N, McCloskey TW, Corondesi M, Chirmule N, and Pahwa S: Accelerated apoptosis in peripheral blood mononuclear cells from HIV infected patients and CD4 crosslinked PBMC from normal individuals. Blood 1993;82:3392.
18. Jamali I, Field EH, Fleming A, and Cowdery JS: Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function. Activation of T cells by the CD3 pathway inhibits anti-CD4-mediated T cell elimination and down-regulation of cell surface CD4. J Immunol 1992;148:1613.
19. Nathan C, Murray H, and Cahn ZA: The macrophage as an effector cell. N Engl J Med 1980;303:622.
20. Jewett A and Bonavida B: Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity. Clin Immunol Immunopathol 1990;54:192.
21. Katz J, Nishanian P, Mitsuyasu R, and Bonavida B: ADCC-mediated destruction of HIV coated CD4+ lymphocytes by AIDS effector cells. J Clin Immunol 1988;8:453.
22. Jewett A, Giorgi J, and Bonavida B: Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients. J Immunol 1990;145:4065.
23. Wang Z, Dudhane A, Orlikowsky T, and Hoffmann MK: T cell antigen receptor engagement abrogates CD4-mediated T cell deletion in vivo. Int Immunol 1994;7:207.
24. Ly IA and Mishell RI: Separation of mouse spleen cells by passage through columns of sephadex G-10. J Immunol Methods 1974;5:239.
25. Dannecker G, Mecheri S, Staiano-Coico L, and Hoffmann MK: A characteristic Mis-1a response precedes Mis-la anergy in vivo. J Immunol 1991;146:2083.
26. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156.
27. Manniatis T, Fritsch EF, and Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1982, p. 473.
28. Celi FS, Zenilman ME, and Shuldiner AR: A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res 1993;21(4):1047.
29. Becton Dickinson: FACScan User's Guide. Becton Dickinson Immunocytometry Systems, San Jose, California, 1989, pp. 4-5.
30. Ding L, Linsley PS, Huang LY, Germain RN, and Shevach E: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J Immunol 1993; 151:1224.
31. Wade WF, Davoust J, Salamero J, Andre P, Watts TH, and Cambier JC: Structural compartmentalization of MHC class II signaling function. Immunol Today 1993;14:539.
32. Zwilling BS, Salkowitz J, Laufman H, and Pearl D: Differences in the expression of histocompatibility antigen-DR and in anti-mycobacterial activity of monocytes from HIV-infected individuals. AIDS 1994;5:1327.
33. Borthwick NJ, Bofill M, Gombert WM, Akbar AN, Medina E, Sagawa K, Lipman MC, Johnson MA, and Janossy G: Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS 1994;8:431.
34. Mittler RS and Hoffmann MK: Synergism between HTV gp120 and gp120 specific antibody in blocking human T cell activation. Science 1989;245:1380.
35. + T cells in human-PBL-SCID mice by noncy-topathic HIV isolates. Science 1993;260:689.
36. Nara P, Hatch W, Kessler J, Kelliher J, and Carter S: The biology of human immunodeficiency virus-1 IIIb infection in the chimpanzee: In vivo and in vitro correlations. J Med Primatol 1989;18:343.
37. Schuitemaker H, Meyaard L, Kootstra NA, Dubbes R, Otto SA, Tersmette M, Heeney JL, and Miedema F: Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis 1993;168:1140.
38. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, and Ho DD: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993;261:1179.
39. van't Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, and Schuitemaker H: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994;94:2060.